Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Department of Immunobiology, Yale School of Medicine, New Haven, United States
Irina Shchukina
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, United States
Yun-Hee Youm
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Department of Immunobiology, Yale School of Medicine, New Haven, United States
Hua Qing
Department of Internal Medicine, Yale School of Medicine, New Haven, United States
Brandon Hilliard
Department of Internal Medicine, Yale School of Medicine, New Haven, United States
Tamara Dlugos
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Department of Immunobiology, Yale School of Medicine, New Haven, United States
Xinbo Zhang
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States
Yuki Yasumoto
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States
Carmen J Booth
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States
Carlos Fernández-Hernando
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale School of Medicine, New Haven, United States
Yajaira Suárez
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale School of Medicine, New Haven, United States
Kamal Khanna
Department of Microbiology, New York University Langone Health, New York, United States
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale School of Medicine, New Haven, United States; Yale Center for Research on Aging, New Haven, United States
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale School of Medicine, New Haven, United States
Maxim Artyomov
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, United States
Department of Immunobiology, Yale School of Medicine, New Haven, United States; Department of Internal Medicine, Yale School of Medicine, New Haven, United States
Department of Comparative Medicine, Yale School of Medicine, New Haven, United States; Department of Immunobiology, Yale School of Medicine, New Haven, United States; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale School of Medicine, New Haven, United States; Yale Center for Research on Aging, New Haven, United States
Increasing age is the strongest predictor of risk of COVID-19 severity and mortality. Immunometabolic switch from glycolysis to ketolysis protects against inflammatory damage and influenza infection in adults. To investigate how age compromises defense against coronavirus infection, and whether a pro-longevity ketogenic diet (KD) impacts immune surveillance, we developed an aging model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain-A59 (MHV-A59). When inoculated intranasally, mCoV is pneumotropic and recapitulates several clinical hallmarks of COVID-19 infection. Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue, and hypothalamus, including neutrophilia and loss of γδ T cells in lungs. Activation of ketogenesis in aged mice expands tissue protective γδ T cells, deactivates the NLRP3 inflammasome, and decreases pathogenic monocytes in lungs of infected aged mice. These data establish harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against coronavirus infection in the aged.